Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341.

2000 Nov

Journal Article

Authors:

Secondary:
Oncology (Williston Park)

Volume:
14

Pagination:
1589-90, 1593-4, 1597

Issue:
11

PMID:
11125942

Keywords:
Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Hematologic Neoplasms; Humans; Neoplasms; Protease Inhibitors; Pyrazines